SCHEMBL6978003

SCHEMBL6978003

O=S(=O)(Nc1ccc2ncccc2c1)c1ccc(F)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.76
LMNA P02545 2/20 0.76
SMN1; SMN2 Q16637 2/20 0.76
PIK3CA P42336 3/20 0.60
GLO1 Q04760 1/20 0.56
KDM4E B2RXH2 1/20 0.55
ALPL P05186 1/20 0.55
HTT P42858 1/20 0.55
HPGD P15428 1/20 0.55
KMT2A Q03164 2/20 0.55
MEN1 O00255 1/20 0.55
HSP90AA1 P07900 1/20 0.54
HSP90AB1 P08238 1/20 0.54
MMP2 P08253 1/20 0.52
NAMPT P43490 1/20 0.51
MAPT P10636 1/20 0.51
PTPN2 P17706 1/20 0.51
PTPN1 P18031 1/20 0.51
PTPN5 P54829 1/20 0.51
RAB9A P51151 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985862 0.87 ALDH1A1 (0.78) ALDH1A1LMNASMN1; SMN2GLO1KDM4E
SCHEMBL9800657 0.87 FFAR4 (0.62) ALDH1A1LMNASMN1; SMN2PIK3CAGLO1
SCHEMBL6978649 0.86 ALDH1A1 (1.00) ALDH1A1LMNASMN1; SMN2KDM4EALPL
SCHEMBL6982196 0.86 ALDH1A1 (0.76) ALDH1A1LMNASMN1; SMN2KDM4EALPL
SCHEMBL6981076 0.86 ALDH1A1 (0.76) ALDH1A1LMNASMN1; SMN2PIK3CAKDM4E
SCHEMBL10654161 0.86 GAA (0.60) ALDH1A1LMNASMN1; SMN2PIK3CAGLO1
SCHEMBL6979083 0.85 SMN1; SMN2 (0.74) ALDH1A1LMNASMN1; SMN2GLO1KDM4E
SCHEMBL1040688 0.83 ALDH1A1 (0.75) ALDH1A1LMNASMN1; SMN2GLO1KDM4E
SCHEMBL6089373 0.82 ALDH1A1 (0.62) ALDH1A1LMNASMN1; SMN2ALPLKMT2A
SCHEMBL10655458 0.81 AR (0.55) ALDH1A1LMNASMN1; SMN2PIK3CAGLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed